Trial intelligence / Profile preview

Alectinib vs Crizotinib in Treatment-Naive ALK-Positive Advanced NSCLC

CTR20160367Phase 3Completed

Sponsor

Roche

Start

Sep 2016

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1